Design, Synthesis, and Characterization of a Novel Fluoroprobe for Live Human Islet Cell Imaging of Serotonin 5-HT1A Receptor

被引:4
作者
Garvey, Robert W. [1 ,2 ]
Lacivita, Enza [3 ]
Niso, Mauro [3 ]
Duszynska, Beata [4 ]
Harris, Paul E. [1 ,2 ]
Leopoldo, Marcello [3 ]
机构
[1] Columbia Univ, Dept Med, Div Endocrinol, Med Ctr, New York, NY 10033 USA
[2] Columbia Univ, Naomi Berrie Diabet Ctr, Med Ctr, New York, NY 10033 USA
[3] Univ Bari Aldo Moro, Dipartimento Farm Sci Farmaco, Via Orabona 4, I-70125 Bari, Italy
[4] Polish Acad Sci, Maj Inst Pharmacol, Dept Med Chem, Smetna 12, PL-31343 Krakow, Poland
基金
美国国家卫生研究院;
关键词
serotonin; serotonin 1A receptor; fluorescent; microscopy; islets; beta-cells; insulin; vesicles; diabetes; STIMULATED INSULIN-SECRETION; ATYPICAL ANTIPSYCHOTICS; BETA-CELLS; IN-VIVO; BINDING; ANTAGONIST; ACTIVATION; DERIVATIVES; INHIBITION; MODULATION;
D O I
10.1002/cmdc.202100759
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Mounting evidence suggests that the serotonin system serves in signal transmission to regulate insulin secretion in pancreatic islets of Langerhans. Among the 5-HT receptor subtype found in pancreatic islets, serotonin receptor 1A (5-HT1A) demonstrates a unique ability to inhibit beta-cell insulin secretion. We report the design, synthesis, and characterization of two novel fluorescent probes for the 5-HT1A receptor. The compounds were prepared by conjugating the scaffold of the 5-HT(1A )receptor agonist 8-OH-DPAT with two fluorophores suitable for live-cell imaging. Compound 5a {5-(dimethylamino)-N-[5-[(8-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino]pentyl]naphtalen-1-sulfonammide} showed high affinity for the 5-HT1A receptor (K-i = 1.8 nM). Fluoroprobe 5a was able to label the 5-HT1A receptor in pancreatic islet cell cultures in a selective manner, as the fluorescence emission was significantly attenuated by co-administration of the 5-HT1A receptor antagonist WAY-100635. Thus, fluoroprobe 5a showed useful properties to further characterize this unique receptor's role.
引用
收藏
页数:10
相关论文
共 44 条
  • [21] 5-HT1A receptor, an old target for new therapeutic agents
    Lacivita, Enza
    Leopoldo, Marcello
    Berardi, Francesco
    Perrone, Roberto
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (12) : 1024 - 1034
  • [22] N-[ω-[4-(2-methoxyphenyl)-1-piperazinyl]alkyl]-2-quinolinamines as high-affinity fluorescent 5-HT1A receptor ligands
    Lacivita, Enza
    Leopoldo, Marcello
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (05) : 1492 - 1495
  • [23] Identification of a red-emitting fluorescent ligand for in vitro visualization of human serotonin 5-HT1A receptors
    Lacivita, Enza
    Masotti, Anna Carmela
    Jafurulla, Md.
    Saxena, Roopali
    Rangaraj, Nandini
    Chattopadhyay, Amitabha
    Colabufo, Nicola A.
    Berardi, Francesco
    Perrone, Roberto
    Leopoldo, Marcello
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (22) : 6628 - 6632
  • [24] Synthesis and Characterization of Environment-Sensitive Fluorescent Ligands for Human 5-HT1A Receptors with 1-Arylpiperazine Structure
    Lacivita, Enza
    Leopoldo, Marcello
    Masotti, Anna Carmela
    Inglese, Carmela
    Berardi, Francesco
    Perrone, Roberto
    Ganguly, Sourav
    Jafurulla, Md
    Chattopadhyay, Amitabha
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (23) : 7892 - 7896
  • [25] Lam Daniel D, 2007, Expert Rev Mol Med, V9, P1
  • [26] Developments in fluorescent probes for receptor research
    Leopoldo, Marcello
    Lacivita, Enza
    Berardi, Francesco
    Perrone, Roberto
    [J]. DRUG DISCOVERY TODAY, 2009, 14 (13-14) : 706 - 712
  • [27] INHIBITION OF GLUCAGON-RELEASE BY SEROTONIN IN MOUSE PANCREATIC-ISLETS
    MARCO, J
    HEDO, JA
    VILLANUEVA, ML
    [J]. DIABETOLOGIA, 1977, 13 (06) : 585 - 588
  • [28] Millan MJ, 2000, SYNAPSE, V35, P79, DOI 10.1002/(SICI)1098-2396(200002)35:2<79::AID-SYN1>3.0.CO
  • [29] 2-X
  • [30] 2-(ALKYLAMINO)TETRALIN DERIVATIVES - INTERACTION WITH 5-HT1A SEROTONIN BINDING-SITES
    NAIMAN, N
    LYON, RA
    BULLOCK, AE
    RYDELEK, LT
    TITELER, M
    GLENNON, RA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (01) : 253 - 256